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Abstract 1 
Cardiovascular diseases (CVD) remain the leading cause of death globally. Effective dietary 2 
strategies for their prevention are of high priority. Increasing evidence suggests that 3 
phytochemicals, particularly dietary flavonoids and nitrates, are key modulators of CVD risk 4 
reduction through impact on multiple risk factors. The aim of this review is to explore the evidence 5 
for the impact of flavonoid- and nitrate-rich foods and supplements on CVD risk, with specific 6 
reference to their importance as mediators of vascular health and platelet function. There is 7 
accumulating evidence to support benefits of dietary flavonoids on cardiovascular health. Dose-8 
dependent recovery of endothelial function and lowering of blood pressure have been reported for 9 
the flavanol (-)-epicatechin, found in cocoa, apples and tea, through production and availability of 10 
endothelial nitric oxide (NO). Furthermore, flavonoids, including quercetin and its metabolites, 11 
reduce in vitro and ex vivo platelet function via inhibition of phosphorylation-dependent cellular 12 
signalling pathways, though further in vivo studies are required to substantiate these mechanistic 13 
effects. Hypotensive effects of dietary nitrates have been consistently reported in healthy subjects in 14 
acute and chronic settings, though there is less evidence for these effects in patient groups. 15 
Proposed mechanisms of actions include endothelial-independent NO availability, which is 16 
dependent on the entro-salivary circulation and microbial conversion of dietary nitrate to nitrite in 17 
the mouth. In conclusion, flavonoid and nitrate-rich foods show promising effects on vascular 18 
function, yet refinement of qualitative dietary guidelines will require confirmation of this evidence, 19 
together with further randomly controlled trials for determination of effective doses.  20 
 21 
 22 
  23 
 3 
Introduction 24 
Cardiovascular diseases (CVD) are the leading cause of mortality globally, accounting for around 25 
31 % of deaths each year(1). In the UK CVD was the second most common cause of death in 2014, 26 
responsible for 27 % of all mortalities(2). There are several recognised risk factors for CVD 27 
including raised serum low-density lipoprotein (LDL)-cholesterol and triacylglycerol (TAG), low 28 
serum high-density lipoprotein (HDL)-cholesterol, elevated blood pressure, diabetes and obesity 29 
many of which can be modified by the lifestyle choices, including diet(3).  Epidemiological data 30 
from the 1970’s indicated that coronary heart disease (CHD) rates were higher in countries with low 31 
fruit and vegetable consumption(4). This has been supported by a number of more recent studies that 32 
have shown that dietary patterns rich in fruit and vegetables are associated with reduced rates of 33 
CHD, stroke and CVD mortality(5; 6; 7; 8; 9; 10). Some researchers have attempted to identify the types 34 
of fruits and vegetables responsible for the reduced risk of CVD. Joshipura et al in 2001 showed 35 
that people in the highest quintile of fruit and vegetable intake had a 20% lower relative risk (RR) 36 
for CHD compared with those in the lowest quintile of intake. In addition, each 1 serving per day 37 
increase in fruit and vegetable intake was associated with a 4 % lower risk of CHD. They also 38 
found that vitamin C-rich fruits (6 % lower RR per 1 serving/day increase) and particularly green 39 
leafy vegetables (23 % lower RR per 1 serving/day increase) had the largest protective effects(5).  40 
Fruits and vegetables are a rich source of phytochemicals such a flavonoids and dietary nitrates, 41 
which have been shown to independently exert a number of health effects and could be responsible, 42 
at least in part, for the apparent protective effects of fruit and vegetable consumption. The aim of 43 
this review is to provide a brief overview of evidence related to the effects of flavonoids and dietary 44 
nitrates on cardiovascular health with particular reference to vascular and platelet function.  45 
 46 
Dietary flavonoids 47 
The main categories of phytochemicals are polyphenols, which include flavonoids, terpenoids, 48 
nitrogen-containing alkaloids and sulphur-containing compounds. Flavonoids are produced by 49 
plants as secondary metabolites and have biological roles in plant pigmentation, flavour, growth, 50 
reproduction, predator and pathogen resistance(11). They are present in a variety of foods including 51 
vegetables, fruits, nuts, grains, red wine and chocolate, in concentrations that vary due to a number 52 
of factors, including environmental stress, such as UV exposure(12). Flavonoids consist of two 53 
benzene rings linked by a 3-carbon chain (C6-C3-C6) as shown in Figure 1. The flavonoid classes 54 
differ due to the C ring structural differences, number of phenolic hydroxyl groups and their 55 
substitutions, and are commonly divided into seven structural subclasses namely: isoflavones, 56 
flavanols or catechins, flavanonols, flavonols, flavanones, flavones, anthocyanins and 57 
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anthocyanidins(13) (Figure 2). The small structural variations between subclasses are related to 58 
considerable differences in biological functions. 59 
 60 
Absorption and Metabolism of flavonoids 61 
Flavonoids are commonly found in the diet as conjugated esters, glycosides or polymers, which 62 
have limited bioavailability, requiring intestinal enzyme hydrolysis or colonic microbiota 63 
fermentation before absorption into the circulation. Aglycones formed in the intestine by cleavage 64 
of flavonoid side chains can enter the epithelial cell by passive diffusion(14). However polar 65 
glucosides can be actively transported into epithelial cells via the sodium-dependent glucose 66 
transporter 1 (SGLUT1), where they are hydrolysed by intracellular enzymes to the aglycone(15). 67 
The importance of the latter absorption route is unclear, but glycosylated flavonoids and aglycones 68 
have been shown to inhibit the SGLUT1 transporter, potentially reducing dietary glucose 69 
absorption(16). Before transport to the circulation, the aglycones also undergo further metabolism 70 
(Phase II) and conjugation including glucuronidation, methylation or sulfation. Efflux of the 71 
metabolites back into the intestine also occurs via transporters including multidrug resistance 72 
protein and P-glycoprotein and the glucose transporter GLUT2(17). Further Phase II metabolism 73 
occurs in the liver via portal vein transportation and further recycling into the intestinal lumen via 74 
the enterohepatic recirculation in bile(18).  Some flavonoids, particularly polyphenol sugar 75 
conjugates, pass unabsorbed into the colon and are associated with marked modulation of the 76 
colonic gut microbiota(19) and the production of principally small phenolic acid and aromatic 77 
catabolites, which are subsequently absorbed into the circulation(20). These metabolites can be 78 
subjected to further metabolism in the liver before they are efficiently excreted in the urine in 79 
quantities far higher than those that entered the circulation via the intestine(21). Due to the extensive 80 
metabolism and rapid excretion, plasma concentrations do not reflect quantitative absorption and 81 
total urinary metabolite excretion can be a more valuable biomarker of intake. Evidence for tissue 82 
accumulation of polyphenols and their metabolites is very limited and while this can’t be ruled out, 83 
it is believed that frequent ingestion of flavonoid-rich foods is required to maintain constant 84 
circulating levels (see review (22)). Detailed studies using stable isotopes have allowed the 85 
determination of metabolic pathways of certain polyphenol subclasses. Anthocyanins, found in 86 
foods such as berries, are reported to have low bioavailability, but recent data have shown they are 87 
extensively metabolised to a diverse range of metabolites, which has highlighted a previous 88 
underestimation of anthocyanin absorption and metabolism(23).  89 
 90 
Flavonoid intake and CVD risk: Epidemiological studies  91 
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Epidemiological studies have produced strong evidence for the negative association between high 92 
fruit and vegetable consumption and cardiovascular disease mortality(24; 25). Yet it is difficult to 93 
identify the specific mediator(s) of health due to the numerous potential bioactive compounds 94 
present in fruits and vegetables. Observational studies suggest that intakes of flavonoids are 95 
associated with a decreased risk of CVD, although the findings are not entirely consistent, because 96 
of variation in population studied, dose and specific flavonoid consumed. Data from a large post-97 
menopausal cohort identified a negative association between flavonoid-rich diets and CVD 98 
mortality(26). Further evidence showed intakes of flavanol- and procyanidin-rich foods were 99 
associated with decreased risk of chronic non-communicable diseases particularly CVD(27; 28). In 100 
2005, Arts and Hollman collated data from 15 prospective cohort studies, of these 13 provided 101 
evidence for a positive association between dietary flavanols, procyanidins, flavones and flavanones 102 
and CVD health, with a reduction of CVD mortality of approximately 65 %(29). Systematic 103 
reviews(30; 31; 32) that have focused on flavonol intake have reported inconsistent findings including 104 
an inverse association between high flavonol intake and CHD or stroke mortality(31; 32) compared 105 
with no association between flavonol intake and CHD risk(30). However, a more recent 106 
comprehensive systematic review and meta-analysis of 14 studies identified that intakes of 107 
anthocyanidins, proanthocyanidins, flavones, flavanones and flavan-3-ols were associated with 108 
lower CVD RR of 11 %, 10 %, 12 %, 12 % and 13 % respectively when comparing the highest and 109 
lowest categories of intake; with a 5 % lower RR for CVD for every 10mg/d increment in flavonol 110 
intake(33).  111 
 112 
An inverse association between flavanol intake and CVD mortality was initially identified in the 113 
Iowa women health study, which followed 34,489 women, free of CVD at study inclusion (34) while, 114 
a subsequent follow-up found no association between reduced CVD risk and flavanol intake, 115 
instead an association with procyanidin intake(26). These seemingly contrasting findings were due to 116 
the different ways the data from chocolate and seeded grapes were categorized in the dietary 117 
assessment, and emphasises the importance of standardisation of dietary assessment, and the 118 
possible benefits of using biomarkers of intake. Evidence from prospective cohort studies generally 119 
supports the hypothesis that a greater intake of dietary flavonoids is associated with a lower risk of 120 
CVD, although there are inconsistencies in potential benefit. Further supportive evidence from 121 
well-performed randomly controlled dietary intervention studies is required to establish a direct 122 
relationship between different flavonoid sub-groups and CVD risk. 123 
 124 
Chronic and acute effects of flavonoid intake on micro- and macrovascular function 125 
The vascular endothelium plays a key role in the regulation of vascular homeostasis, and alterations 126 
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in endothelial function contribute to the pathogenesis and clinical expression of CVD(35). Many 127 
factors impact adversely on the endothelium, these include diabetes mellitus, smoking, physical 128 
inactivity, aging, hypertension, systemic inflammation, dyslipidaemia and insulin resistance, with 129 
diet being key in modulating endothelial function(36; 37). Prospective cohort studies have supported 130 
the association between endothelial function and an increased risk of CVD events and have 131 
identified the latter as a valuable holistic surrogate marker of CVD risk(38; 39). Endothelial 132 
dysfunction has been associated with the development of atherosclerosis and CVD(40) and is most 133 
commonly measured in the brachial artery by flow mediated dilatation (FMD), which uses non-134 
invasive ultrasound before and after increasing shear stress by reactive hyperaemia, with the degree 135 
of dilation reflecting arterial NO release. Another commonly used technique is laser Doppler 136 
imaging with iontophoresis (LDI), which measures the endothelial function of the peripheral 137 
microcirculation. The degree of endothelial dysfunction occurring in the microcirculation has been 138 
shown to be proportional to that occurring in the coronary arteries(41). This technique measures the 139 
response of cutaneous blood vessels to transdermal delivery of two contrasting vasoactive agents: 140 
acetylcholine (endothelium-dependent vasodilator) and sodium nitroprusside (endothelium-141 
independent vasodilator) by iontophoresis. A reduced local vasodilatory response to acetylcholine is 142 
associated with endothelial dysfunction(42). 143 
 144 
Consumption of fruits rich in anthocyanins and proanthocyanidins in the form of purple grape juice 145 
or grape seed extract (for between 14-28 days) significantly increased FMD in volunteers with 146 
angiographically documented CHD or above average vascular risk(43). Furthermore, consumption of 147 
pomegranate, containing tannins and anthocyanins, for a period of 90 days to 3 years resulted in 148 
improvements in carotid intermedia thickness (CIMT), a measure of the extent of atherosclerosis in 149 
the carotid artery, in those with increased CVD risk(43). The FLAVURS study investigated the dose-150 
dependent effect (+2, +4 and +6 additional portions/d) of flavonoid-rich and flavonoid-poor fruits 151 
and vegetables compared to habitual diet, on microvascular reactivity, determined by LDI, and 152 
other CVD risk markers. After two additional portions of flavonoid-rich fruits and vegetables, 153 
equivalent to an estimated increase in total dietary flavonoids from 36  5 to 140  14 mg/d(44), a 154 
significant increase in endothelium-dependent microvascular reactivity was observed in men. In 155 
addition, reduced C-reactive protein, E-selectin and vascular cell adhesion molecule, and increased 156 
plasma NOx was observed with four additional flavonoid-rich portions, compared to the control and 157 
low-flavonoid intervention(45). This data supports vascular improvements reported in a previous 158 
study investigating a similar single dose of flavonoid-rich foods(46). Identification of the specific 159 
flavonoid bioactive is not possible in studies that include a variety of foods, yet these data 160 
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demonstrate that dietary relevant doses of total flavonoids can contribute to vascular health and 161 
could be considered as useful strategies for CVD risk factor reduction.  162 
 163 
The majority of the population is in a postprandial state for most of the day and it is recognized that 164 
acute physiological responses to meals are a major contributor to overall CVD risk. Flavonoid-rich 165 
foods have been implicated in modulating postprandial responses. For example blueberries are a 166 
rich source of flavonoids, particularly anthocyanin, flavanol oligomer, and chlorogenic acid(47). 167 
Acute improvements in vascular function, measured by FMD, were observed in healthy men in a 168 
time- and dose-dependent manner (up to a concentration of 766mg total polyphenols)(48) with little 169 
observed effect of processing(47). These beneficial effects on postprandial vascular reactivity are not 170 
confined to blueberries, as a mixed fruit puree containing, 457 mg (-)-epicatechin increased 171 
microvascular reactivity and plasma NOx(49). Although the fruit puree contained varied flavonoids, 172 
the potential vascular benefits of (-)-epicatechin is supported by a meta-analysis of six randomly 173 
controlled trials which found that 70-177 mg  (-)-epicatechin, from cocoa or chocolate sources 174 
significantly increased postprandial FMD by 3.99 % at 90-149 min post ingestion(50). These data 175 
indicate that different classes of flavonoids in the form of foods can significantly improve 176 
postprandial vascular function and possible CVD risk. 177 
 178 
Flavanols, as a subgroup of flavonoids, have been extensively studied and increasing evidence has 179 
shown that higher intake of flavanol-rich foods improve arterial function in numerous groups 180 
including those at risk for CVD, with established CVD(51) and more recently healthy young and 181 
aging individuals(52). The mechanisms of action are not totally understood, but causality between 182 
intake and an improvement in arterial function has been demonstrated(53). The important dietary 183 
flavonol, (-)-epicatechin, is naturally present is high concentrations in cocoa, apples and tea and a 184 
number of systematic reviews and meta-analyses, including a recent study of 42 randomised 185 
controlled human dietary intervention studies on supplemental and flavan-3-ols-rich chocolate and 186 
cocoa, reported significant acute and chronic (up to 18 weeks) dose-dependent cardiovascular 187 
benefits, including recovery of endothelial function, lowering of blood pressure and some 188 
improvements in insulin sensitivity and serum lipids(50; 54; 55). Furthermore green and black tea (rich 189 
in (-)-epicatechin) was also reported to reduce blood pressure and LDL-cholesterol in a systematic 190 
review and meta-analysis of a small number of studies, but these findings need confirmation in 191 
long-term trials, with low risk of bias(56). The extensive studies into the vascular effects of (-)-192 
epicatechin and their impact on other CVD risk markers has prompted some to propose specific 193 
dietary recommendation for these flanonoids and a broader recommendation on flavanol-rich fruits 194 
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and vegetables for CVD risk reduction, although further evidence may be required before specific 195 
recommendations are considered.(57) 196 
 197 
Possible mechanisms of flavonoids and vascular effects  198 
Despite the high antioxidant potential of a number of classes of flavonoids, there is limited evidence 199 
to support this mechanism of action due to the low plasma concentrations of flavonoids compared 200 
with other endogenous or exogenous antioxidants(58). Many of the vascular effects of flavonoids 201 
have been associated with molecular signalling cascades and related regulation of cellular function. 202 
One of the potential mechanisms of action is the association between flavonoid, particularly (-)-203 
epicatechin, and prolonged, augmented nitric oxide (NO) synthesis, the primary modulator of 204 
vascular dilation(53). NO production from L-arginine is regulated by three nitric oxide synthase 205 
(NOS) enzymes: endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS) with 206 
lower production and/or availability of NO as the main effect on endothelial dysfunction. Several in 207 
vitro and human studies have reported potent vasorelaxant activity of certain flavonoids related to 208 
activation of eNOS(53; 59). A common polymorphism in the eNOS gene is the Glu298Asp single-209 
nucleotide polymorphism that modifies its coding sequence, replacing a glutamate residue at 210 
position 298 with an aspartate residue. This polymorphism has been linked to increased risk of 211 
cardiovascular events putatively through reduced NO production by eNOS(60; 61). Interestingly, in a 212 
small acute randomized control study a significant genotype interaction with endothelium-213 
dependent microvascular dilation was observed after consumption of fruit and vegetable puree 214 
containing 456 mg (-)-epicatichin. Wild-type, GG, participants (non-risk group) showed an 215 
increased endothelial vasodilation at 180 min compared to control, with no effect in T allele 216 
carriers. This supports the importance of (-)-epicatichin in eNOS activation and NO availability, 217 
with little vascular effect of (-)-epicatichin in those with impaired eNOS function. This nutrient-218 
gene interaction may explain in part, the large variation in individual vascular responses to 219 
flavonoid consumption, but requires further confirmatory studies(62).  220 
 221 
Flavonoids have also been reported to modulate xanthine oxidase activity, resulting in decreased 222 
oxidative injury and consequential increased NO(63). The vascular effects induced by phenolics may 223 
also be mediated by the inhibition of Ca2+ channels and/or the blockage of the protein kinase C-224 
mediated contractile mechanism, as has been observed for caffeic acid phenyl ester and sodium 225 
ferulate, respectively(64). Furthermore, benefits may be mechanistically linked to the actions of 226 
circulating phenolic metabolites on inhibition of neutrophil nicotinamide adenine dinucleotide 227 
phosphate (NADPH) oxidase activity, which prevents NO degradation and increases its 228 
availability(48).  More recently a possible role of flavonoid promotion of endothelium-derived 229 
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hyperpolarizing factor (EDHF) in vasodilation, which induces hyperpolarization, thus leading to 230 
dilation of the vascular smooth muscle cell has been identified(65). In summary there are multiple 231 
potential mechanisms by which flavonoids and their metabolites can modulate vascular function(66) 232 
and these may act in an additive or synergistic manner. It is evident that dietary relevant doses of 233 
flavonoids are associated with vascular benefit with varied proposed modulating mechanisms that 234 
require elucidation in further studies. 235 
 236 
Flavonoids and platelet aggregation 237 
Platelets are small nucleated cell fragments that are produced by megakaryocytes in the bone 238 
marrow(67; 68) and play a critical role in haemostasis through formation of aggregates over arterial 239 
wall injuries(69). When platelet activation becomes impaired, thrombosis can occur, a 240 
pathophysiological condition which can lead to blockage of coronary arteries or impaired blood 241 
supply to the brain, leading to events such as myocardial infarction (MI) or stroke(70). Many studies 242 
have previously shown the ability of flavonoids to inhibit platelet function(71; 72; 73). Quercetin is 243 
found in many foods such as apples, onions, tea and wine, and present in significant quantities in 244 
many diets (74). Further understanding of how quercetin modulates platelet function is of relevance 245 
to establish a mechanistic link between flavonols and CVD risk.  246 
Hubbard et al.(75) observed a significant inhibition of ex vivo platelet aggregation after ingestion 247 
of quercetin-4’-O- -D-glucoside at a dose of 150 mg and 300 mg, with peak quercetin metabolite 248 
concentrations of 4.66 M and 9.72 M respectively. This data was supported by a further small 249 
human study which reported at peak plasma quercetin metabolite concentrations of 2.59 M and 250 
significant inhibition of ex vivo collagen-stimulated platelet aggregation 60 and 240 min after 251 
consumption of a high-quercetin onion soup rich in quercetin glucosides (68.8 mg total quercetin) 252 
compared with a matched low quercetin onion control (4.1 mg total quercetin)(76). Inhibition of 253 
Spleen Tyrosine Kinase (SYK) and Phospholipase C2 (PLC2), two key platelet proteins involved 254 
with the collagen-stimulated signalling pathway were also observed, and confirms this as one 255 
potential mechanism of action. These data are in agreement with previous in vitro studies displaying 256 
the ability of quercetin to inhibit collagen, ADP and thrombin-stimulated platelet aggregation, as 257 
well as inhibiting collagen-stimulated Mitogen-Activated Protein (MAP) kinases and 258 
Phosphoinositide 3-kinase (PI3K) phosphorylation(77; 78). 259 
 Flavonoids undergo significant endogenous metabolism and it is important to determine the 260 
bioactivity of metabolites as well as the aglycones by understanding structure-activity relationships 261 
and how functional groups affect platelet function. Anti-platelet effects of tamarixetin, quercetin-3-262 
sulphate and quercetin-3-glucuronide, as well as the structurally distinct flavonoids apigenin and 263 
catechin, quercetin and its plasma metabolites were determined. Quercetin and apigenin 264 
 10 
significantly inhibited collagen-stimulated platelet aggregation and 5-HT secretion with similar 265 
potency, and logIC50 values for inhibition of aggregation of -5.17 (0.04) and -5.31 (0.04), 266 
respectively(79). Flavones (such as apigenin) are characterized by a non-hydroxylated C-ring, 267 
whereas the C-ring of flavonols (e.g. quercetin) contain a C-3 hydroxyl group (Figure 1). Catechin 268 
was less effective, with an inhibitory potency two orders of magnitude lower than quercetin, 269 
suggesting that in vivo, metabolites of quercetin and apigenin may be more relevant in the inhibition 270 
of platelet function. Flavan-3-ols such as catechin possess a non-planar, C-3 hydroxylated C ring, 271 
which is not substituted with a C-4 carbonyl group (as is found in flavonols). Quercetin-3-sulphate 272 
and tamarixetin (a methylated quercetin metabolite) were less potent than quercetin, with a 273 
reduction from high to moderate potency upon addition of a C-4’ methyl or C-3’-sulphate group, 274 
but at concentrations above 20 M, all achieved substantial inhibition of platelet aggregation and 5-275 
HT release. Quercetin-3-glucuronide caused much lower levels of inhibition, providing evidence for 276 
reduced potency upon glucuronidation of the C ring. Jasuja et. al have shown quercetin-3-277 
glucuronide to potently inhibit protein disulphide isomerase (PDI), an oxidoreductase important in 278 
thrombus formation(80). X-ray crystallographic analyses of flavonoid-kinase complexes have shown 279 
that flavonoid ring systems and the hydroxyl groups are important features for kinase binding (81) (82) 280 
supporting the evidence for structure-specific effects on platelet function. Taken together, this 281 
evidence shows the importance of understanding the structural differences of flavonoids, and how 282 
specific functional groups on polyphenols can lead to enhanced or reduced effects in different 283 
stages of haemostasis and thrombosis. This evidence may also facilitate the design of small-284 
molecular inhibitors and inform specific dietary advice. 285 
 286 
In summary, flavonoids are generally poorly absorbed and substantially metabolised to aid rapid 287 
elimination. Many flavonoid subgroups reach the colon in their native state, and are fermented by 288 
the microbiota, which produces small phenolic metabolites with potential bioactivity after 289 
absorption. CVD risk reduction from high fruit and vegetable intake may be due, in part, to benefits 290 
from flavonoid ingestion. In particular, (-)-epicatechin, a key flavanol, has been causally linked 291 
with increased arterial endothelial-dependent dilation measured by FMD, with a putative increase in 292 
NO bioavailability.  Other potential mechanisms of action include modulation of NADPH oxidase 293 
activity and reduction of NO degradation. Furthermore, flavonoids, particularly quercetin and its 294 
metabolites, reduce in vitro and ex vivo platelet function, possibly via inhibiting phosphorylation in 295 
cell signalling cascades.  Further research will be required to determine the biological effects of 296 
flavonoid subgroups in vivo, and the minimal effective dose of these compounds before it is 297 
possible to make any specific dietary recommendations. 298 
   299 
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  300 
Inorganic nitrate and nitrite 301 
Inorganic nitrate and nitrite were previously considered largely inactive by products of the 302 
oxidation of NO endogenously. However, emerging evidence suggest these anions are important 303 
storage forms of NO, which can be reduced to bioactive NO under certain conditions. Nitrate is 304 
particularly abundant in vegetables such as beetroot and green leafy varieties (spinach, lettuce, 305 
rocket) where it is absorbed from the soil and transported to the leaf where it accumulates. Nitrate is 306 
important for plant function and is the main growth-limiting factor. In UK diets, estimates from 307 
1997 suggest that the average nitrate intake is approximately 52 mg/day, with vegetables being the 308 
main source of nitrate, contributing around 70 % of daily intakes with the remaining nitrate derived 309 
from drinking water(83).    310 
The consumption of inorganic nitrate either from dietary or supplemental sources have been 311 
shown to exert a number of important vascular effects such as blood pressure lowering, protection 312 
against ischemia-reperfusion injury, inhibiting platelet aggregation, preserving or improving 313 
endothelial dysfunction and enhancing exercise performance(84).  314 
 315 
The nitrate-nitrite-NO pathway 316 
The continuous generation of NO from L-arginine by the enzymatic action of eNOS in the presence 317 
of oxygen within endothelial cells is important for maintenance of vascular homeostasis. Indeed 318 
reduced production or bioavailability of NO is associated with a number of cardiovascular and 319 
metabolic disorders(85). The nitrate-nitrite-NO pathway is a NOS and oxygen independent pathway 320 
for the generation of bioactive NO, and is an important alternative pathway for NO production, 321 
particularly during periods of hypoxia(86). Ingested nitrate, obtained mainly from green leafy 322 
vegetables and beetroot, is readily absorbed in the upper part of the gastrointestinal tract where it 323 
mixes with NO produced from NOS (87).  324 
 325 
Ingested nitrate peaks after approximately 1 hour(88) and remains elevated for up to 5-6 hours post 326 
ingestion. The majority of ingested nitrate (65-75 %) is excreted in urine with a very small 327 
proportion of nitrate (<1 %) reaching the large bowl, which is excreted in the faeces(89). The 328 
remaining nitrate is reabsorbed by the salivary glands and concentrated up to 20-fold, reaching 329 
concentrations of 10 mM in the saliva(90). Salivary nitrate is converted to nitrite via a two-electron 330 
reduction, a reaction that mammalian cells are unable to perform, during anaerobic respiration by 331 
nitrate reductases produced by facultative and obligate anaerobic commensal oral bacteria(86; 91). 332 
The importance of oral bacteria in the nitrate-nitrite-NO pathway has been demonstrated in a 333 
number of studies(88; 92; 93). When the nitrite rich saliva reaches the acidic environment of the 334 
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stomach some of it reacts to form nitrous acid, which further decomposes to NO and other reactive 335 
nitrogen oxides(94). The remaining nitrite (approximately 95 %) is absorbed into the circulation(95) 336 
where it forms NO via the action of a number of different nitrite reductases, which have selective 337 
activity under oxygen/hypoxic/ischaemic conditions. These include haemoglobin(96), myoglobin(97), 338 
cytoglobin and neuroglobin(98), xanthine oxidoreductase(99), aldehyde oxidase(100), aldehyde 339 
dehydrogenase type 2(101), eNOS(99), cytochrome P450(102) and the mitochondrial electron transport 340 
chain(103). It is likely that the majority of the cardioprotective effects observed from dietary nitrate 341 
consumption are via the conversion of nitrite to NO in blood and tissues.       342 
 343 
Vascular effects of dietary nitrate and nitrite 344 
Beneficial effects of nitrate consumption on vascular related function was first identified by Larsen 345 
et al.(104), who showed that supplementation of healthy humans for three days with sodium nitrate 346 
reduced blood pressure. Since then, a number of studies have shown that dietary nitrate-rich 347 
vegetable sources such as beetroot juice, spinach, rocket and breads also lower blood pressure and 348 
vascular function in healthy subjects(88; 105; 106; 107).  349 
  350 
Endothelial dysfunction  351 
A hallmark of endothelial dysfunction is the reduced bioavailability of NO, either through reduced 352 
eNOS activity or expression, or via increased NO consumption by free radicals and reactive oxygen 353 
species(108) as discussed above. It has been shown that consumption of 500 mL beetroot juice 354 
containing 23 mmol nitrate reversed the deleterious effects of a mild ischaemia-reperfusion injury 355 
to the forearms of healthy subjects and preserved the FMD response, whereas the response was 356 
reduced by 60 % in the control subjects(88; 93). Hobbs et al.(105) found that consumption of bread 357 
enriched with beetroot increased endothelium-independent blood flow in healthy subjects measured 358 
by LDI. In healthy overweight and slightly obese subjects consumption of 140 mL beetroot juice 359 
(500 mg nitrate) or control alongside a mixed meal (57 g fat) attenuated postprandial impairment of 360 
FMD(109). More recently daily consumption of dietary nitrate in the form of beetroot juice over a 6-361 
week period resulted in a 1.1 % increase in the FMD response compared with a 0.3 % worsening in 362 
the control group (110). However, not all studies have found a beneficial effect of dietary nitrate on 363 
endothelial function, with no effects of 250 mL beetroot juice (7.5 mmol nitrate) on FMD response 364 
in patients with type 2 diabetes (111).  Furthermore, supplemental potassium nitrate consumption (8 365 
mmol nitrate) did not affect FMD response in healthy subjects, although a significant reduction (0.3 366 
m/s) in pulse wave velocity and SBP (4 mm Hg) at 3 h compared with the potassium chloride 367 
control was reported. This suggests that although inorganic nitrate did not alter endothelial function, 368 
it did appear to increase blood flow in combination with reductions in BP.  369 
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 370 
Organic and inorganic nitrate/nitrites are both effective in vascular health, yet it has been proposed 371 
that inorganic dietary nitrate may be a more appropriate choice for vascular modulation than 372 
organic nitrate supplements(112). The enterosalivary circulation is key for the effects of inorganic 373 
nitrate and prevents a sudden effect, or toxic circulating concentrations of nitrite, in addition to 374 
prolonging the vascular effects. In contrast, supplemental organic nitrate, which does not require the 375 
enterosalivary circulation for absorption, has rapid pharmacodynamic responses, causing potent 376 
acute effects, immediate vasodilation, and in chronic use considerably limited by the development 377 
of tolerance and endothelial dysfunction. The more subtle and controlled effects of inorganic nitrate 378 
may compensate for diminished endothelial function, and also has no reported tolerance. Therefore, 379 
with the increasing recognition of the limitations of organic nitrate supplementation, and continuing 380 
discovery of beneficial effects of inorganic nitrate/nitrite, dietary inorganic forms may prove to be 381 
the optimum strategy for vascular health(112).  382 
 383 
eNOS Glu298Asp polymorphism and nitrate interactions 384 
Variation in response to nitrates could be due to genetic polymorphisms. Healthy men 385 
retrospectively genotyped for the Glu298Asp polymorphism (7 GG and 7 T carriers), showed a 386 
differential postprandial BP response after consumption of beetroot-enriched bread compared with 387 
the control bread. A significantly lower DBP in the T carriers was observed with a concomitant 388 
tendency for higher plasma NOx concentration. Despite the small study size these data suggests that 389 
carriers of the T allele, which limits endogenous NO production from endothelial eNOS (113), were 390 
more responsive to dietary nitrate. Cross-talk between NOS-dependent pathway and the nitrate-391 
nitrite-NO pathway in control of vascular NO homeostasis could be a possible explanation for these 392 
observations (114), although future suitably powered studies are needed to confirm these findings.  393 
This nutrient-gene interaction is in contrast to that demonstrated for the same eNOS polymorphism 394 
and dietary flavonoids (described above), and confirms the differential proposed mechanisms by 395 
which flavonoids and nitrates impact on NO availability and vascular function. 396 
 397 
Blood pressure 398 
Dietary nitrate has been shown to reduced SBP and/or DBP, and increase circulating nitrate/nitrite 399 
(see review(115)). These findings are supported by more recent acute and chronic studies conducted 400 
in healthy younger populations (Table 1). A recent meta-analysis of four randomised clinical trials 401 
in older adults (55-76 y) revealed that consumption of beetroot juice did not have a significant 402 
effect on blood pressure. However, consumption of beetroot juice containing 9.6 mmol/d for 3 days 403 
(116), or 4.8-6.4 mmol nitrate/L for three weeks (117) by older adults (60-70 y) significantly lowered 404 
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resting SBP by 5 mmHg and 7.3 mmHg respectively, compared with control. These inconsistent 405 
findings highlight the need for further studies to determine effects in older population groups.  406 
It was concluded from data collated from eight studies conducted in patient groups that dietary 407 
nitrate may help to reduce blood pressure in hypertensive subjects, but not in patients with type 2 408 
diabetes, although only one study could be found in the latter population group(118). Furthermore, 409 
minimal effects were reported in obese insulin resistant individuals (119), and those with chronic 410 
obstructive pulmonary disease despite relatively high doses of dietary nitrate (13.5 mmol/d and 9.6 411 
mmol/d, respectively), although the intervention period was limited (2-3 days)(120; 121). In contrast 412 
consumption of beetroot juice (7.6 mmol/d) by 15 individuals with chronic obstructive pulmonary 413 
disease significantly lowered DBP by 8.2 mmHg (P=0.019) (122). Additional studies are required to 414 
confirm these findings.  415 
   416 
Platelet aggregation 417 
Dietary and supplemental nitrate have been reported to significantly reduce platelet aggregation in 418 
healthy individuals (88; 110; 123). However, a lack of effect was observed in women from one study. A 419 
proposed explanation for this gender difference was reduced soluble guanylyl cyclase (sGC) 420 
activity (123), a hypothesis supported by studies in mice(124; 125), although further conformational 421 
studies are required.  422 
 423 
Metabolic function 424 
The consumption of sodium nitrate by eNOS deficient mice reversed features of the metabolic 425 
syndrome including improvements in blood pressure, bodyweight, abdominal fat accumulation, 426 
circulating TAG levels and glucose homeostasis(126). The improvements in glucose homeostasis by 427 
inorganic nitrate have been shown in a number of other mouse studies(127; 128; 129; 130). For example, 428 
Khalifi et al.(130) examined the effects of dietary nitrate in glucose tolerance and lipid profile in type 429 
2 diabetic rats, and found that supplementation of drinking water with 100 mg/L sodium nitrate 430 
prevented an increase in systolic blood pressure and serum glucose, improved glucose tolerance and 431 
restored dyslipidaemia in an animal model of hyperglycaemia. A possible mechanism for the 432 
beneficial effects of nitrate on glucose homeostasis may be the nitrite-mediated induction of 433 
GLUT4 translocation(131), which enhances cellular uptake of glucose. More recent data has also 434 
shown that dietary nitrate may increase browning of white adipose tissue, which may have 435 
antiobesity and antidiabetic effects(132). Yet there are few studies that have investigated the effects 436 
of dietary nitrate on glucose homeostasis in humans. Gilchrist et al.(111) found that consumption if 437 
250 mL beetroot juice (7.5 mmol nitrate) for two weeks by individuals with type 2 diabetes 438 
increased plasma nitrate and nitrite concentrations, but did not improve insulin sensitivity measured 439 
 15 
by the hyperinsulinaemic isoglycaemic clamp method. In support of this Cermark et al.(133) found 440 
that acute ingestion of sodium nitrate (0.15 mmol nitrate per kg bodyweight) did not attenuate the 441 
postprandial rise in plasma glucose or insulin following an oral glucose tolerance test in individuals 442 
with type 2 diabetes.  443 
 444 
In summary, organic nitrate is now considered to have important benefits on vascular health. While 445 
these benefits include the lowering of postprandial and longer-term blood pressure in healthy 446 
groups, limited data in patient groups prevents the wider translation of these findings. Nitrate-rich 447 
foods have some reported benefits on measures of vascular function, with mechanistic links to 448 
increasing endothelial-independent NO availability through the reduction of nitrate to nitrite, and 449 
NO.  The importance of the entero-salivary circulation and reduction of nitrate to nitrite by oral 450 
microbiota is essential for the functional effects of dietary nitrate. Evidence for the more controlled 451 
and sustained physiological effects of dietary nitrates on vascular health has prompted consideration 452 
of their potential advantage over the rapid effects of nitrate supplements. Further research is 453 
required to determine the lowest effective dose and specific mechanisms of action, particularly in 454 
patients with hypertension and cardiometabolic disease.  455 
 456 
Interactions of nitrate-nitrite with flavonoids  457 
Dietary flavonoids and nitrate affect vascular health by different mechanisms. Flavonoids are 458 
proposed to modulate endothelial-dependent NO release, and nitrates impact on NO production 459 
from nitrite intermediate and it is possible that their combined consumption may result in additive 460 
or synergistic vascular responses. Furthermore formation of NO and other reactive nitrogen species 461 
in the stomach is enhanced by increasing nitrite concentrations, lower stomach pH and the presence 462 
of vitamin C or polyphenols(134; 135; 136). Bondonno et al.(106) investigated the independent and 463 
additive effects of consumption of flavonoid-rich apples and nitrate-rich spinach. They found that 464 
the combination of nitrate and flavonoids did not result in additive effects on NO status, endothelial 465 
function or blood pressure, although independent effects of flavonoid-rich apples and nitrate-rich 466 
spinach on these outcomes were reported. More recently, Rodriguez-Mateos et al.(137) investigated 467 
interactions between cocoa flavanols and nitrate, and demonstrated additive effects on FMD 468 
response when cocoa flavanols and nitrate were consumed at low doses in combination. In addition, 469 
cocoa flavonoids enhanced nitrate related gastric NO formation, supporting previous studies and 470 
suggests nutrient-nutrient interactions may modulate vascular function. Thus there is some evidence 471 
to suggest that nitrates and flavonoids, when consumed in combination, may exert additive effects 472 
on cardiovascular health, but due to the extremely limited data, confirmatory studies are required. 473 
  474 
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 475 
 476 
Conclusions 477 
There is an increasing body of evidence to suggest that dietary flavonoids, particularly flavonols 478 
and anthocyanidins, improve vascular function and lower blood pressure at doses achievable in 479 
diets that are high in foods such as fruits, vegetables, cocoa and teas.  The potential mechanisms of 480 
actions are not fully understood, although increased NO availability via endothelial-dependent 481 
mechanisms have been proposed as a key modulator. Cell signalling-mediated mechanisms are also 482 
important in both platelet and vascular function. Dietary inorganic nitrates are also dietary 483 
modulators of vascular health, primarily through the formation of NO via the nitrate-nitrite-NO 484 
pathway. Promising effects of inorganic nitrate consumption on blood pressure in healthy, 485 
hypertensive and other patient groups have been identified, although many of the current studies are 486 
limited in power and design, particularly those in specific patient groups. It is recognised that 487 
greater potential benefit may be gained from dietary nitrates compared with organic supplements, 488 
with the latter causing an immediate and severe reduction in blood pressure and endothelial 489 
dysfunction. Research is required to determine whether dietary nitrates can be used in combination 490 
with hypotensive therapy which may reduce or eliminate the requirement for medication and the 491 
associated side-effects. Consumption of diets rich in flavonoids and nitrates may be important in 492 
reducing CVD risk and promoting vascular benefit, although results have been inconsistent, and 493 
more long-term studies are required to determine dose-dependent effects and the specific 494 
mechanisms of action.  495 
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Figure 1. Generic structure of a flavonoid consisting of two benzene rings linked by a 3-carbon chain  
 
Figure 2. Structure of the seven classes of flavonoids shown as aglycones  
 
 
Figure 3. Diagram of inorganic nitrate metabolism via the nitrate–nitrite–nitric oxide (NO) pathway (adapted from Hobbs et al., 2013(115)). A 
proportion of ingested nitrate (NO3 
−, - - -▸ ) is converted directly to nitrite (NO2 −, → ) by facultative anaerobic bacteria, that reside in  plaque 
and on the dorsum of the tongue, during mastication in the mouth (a); the remainder is swallowed and is rapidly absorbed from the upper 
gastrointestinal tract. Approximately 25 % is removed from the circulation and concentrated in the salivary glands and re-secreted into the 
mouth, where it is reduced to nitrite. Some of the salivary nitrite enters the acidic environment of the stomach once swallowed (b), where NO is 
produced non-enzymically from nitrite after formation of nitrous acid (HNO2) and then NO and other nitrogen oxides. The NO generated kills 
pathogenic bacteria and stimulates mucosal blood flow and mucus generation. The remaining nitrite is absorbed into the circulation; in blood 
vessels (c) nitrite forms vasodilatory NO after a reaction with deoxygenated Hb (deoxy-Hb). Approximately 60 % of ingested nitrate is excreted 
in urine within 48 h. Oxy-Hb, oxygenated Hb.  
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Table 1. The acute and chronic effects of dietary or inorganic nitrate on blood pressure in healthy subjects 
Reference Subject 
characteristics 
Study design 
and duration 
Nitrate dose and vehicle Placebo BP primary/ 
secondary 
outcome 
Effects on BP* 
Jonvik et 
al.(107) 
Healthy 
n=18 (11 M/ 7 F) 
Age: 28  1 y 
Acute, 0-300 
min, semi-
randomised, 
crossover 
Sodium nitrate (0.58 mM/L) 
Beetroot juice (0.60 mM/L) 
Rocket salad (0.58 mM/L) 
Spinach (0.58 mM/L) 
n/a Primary SBP -5 mmHg for beetroot juice 
(P<0.001), -6 mmHg for rocket salad 
(P=0.007) from 0-150 min and -7 
mmHg for spinach from 0-300 min 
(P<0.001), sodium nitrate no change. 
DBP -3 mmHg rocket salad (P=0.045) 
and -6 mmHg spinach (P<0.001) from 
0-300 min. No change in sodium 
nitrate and beetroot juice.   
Ashworth 
et al.(138) 
Healthy 
n=19 F 
Age: 20  2 y 
Chronic, 1 
week, 
randomised, 
crossover 
High nitrate vegetable diet 
 
Low 
nitrate 
vegetable 
diet 
Primary SBP -4 mmHg (P<0.05) 
DBP no change 
Jovanovski 
et al.(139) 
Healthy 
n=27 (11 M/ 16 
F) 
Age: 25  11 y 
Chronic, 1 
week, 
randomised, 
placebo 
controlled, 
single blind 
crossover 
Spinach soup (13.6 mM/d) Asparagus 
soup (0.01 
mM/d) 
Primary SBP -4.1 mmHg (P<0.01) 
DBP -4.4 mmHg (P<0.05) 
Keen et 
al.(140) 
Healthy 
n=6 M 
Age: 24  1 y 
Chronic, 3 
days 
Beetroot juice (5 mM/d) n/a Secondary SBP no change 
DBP -12 mmHg (P=0.004) 
MAP -7 mmHg (P<0.001) 
M, male; f, female; y, years; n/a, not available; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure. * 
refers to differences from baseline.  
